Devices, digital health, and the technology changing how care is delivered.
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer appeared first on MedCity News .
CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery appeared first on MedCity News .
Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from monitoring are less likely to adopt the tools, according to Rock Health.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.
Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded. The post The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing appeared first on MedCity News .
Replacing a paper clipboard with a QR code on your phone doesn’t kill the clipboard; it’s just a better clipboard. Why? The burden is still on the patient. It’s the digital version of carrying a manila folder of records across town. This is a half-measure. It’s not true interoperability. The post Kill the Clipboard Tax appeared first on MedCity News .
AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post AI in Drug Discovery: Surveying the Breadth of the Challenges appeared first on MedCity News .
[Sponsored] A checklist for AI readiness from Nordic aims to help healthcare organizations avoid failure. The post Is Your Healthcare Organization Ready to Implement AI? appeared first on MedCity News .
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News .
Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs. The post Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment appeared first on MedCity News .
Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News .
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
Rural healthcare has always run on ingenuity, resilience, and community trust. What has too often been missing is the infrastructure strong enough to match that and sustain it at scale. That is what makes this moment different. The post Building the Backbone of Rural Health: Meeting the Reality on the Ground appeared first on MedCity News .
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identif
PURPOSE While point-of-care ultrasound (POCUS) has been integrated into daily practice by general practitioners (GPs) in some countries, there is a paucity of literature documenting its use by Chinese GPs. Additionally, artificial intelligence (AI)-assisted diagnosis is increasingly applied to imaging equipment. This study aims to explore the diagnostic performance of GPs in carotid plaque detection using AI-enhanced POCUS after systematic training. METHODS This diagnostic accuracy trial was conducted in Shanghai, where 7 GPs received systematic training then recruited patients with high…
HTI-5 proposed regulations seek to modernize health IT and interoperability, but ACP warns the degree of change and accelerated implementation period are too aggressive.
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
Toolkit Clinical decision support (CDS) alerts can signal the existence of conditions that degrade care quality. This toolkit provides primary care and other ambulatory care environments steps to amend information systems to adopt a community-acquired pneumonia (CAP) alert to improve workflows that affect the diagnosis and management of CAP. Available at Agency for Healthcare Research and Quality . Share Facebook <a tabindex="0" class="dropdown-item" target="_blank" rel="nofollow" href="https://twitter.com/share?text=Community-Acquired Pneumonia Clinical Decision Support Implementation…
Looking to spark an antibody-like revolution for RNA interference medicines, City Therapeutics has landed a nearly $100 million series B to fund a clinical push and power further development of its foundational platform.
A Dexcom continuous glucose monitor helped adults with type 2 diabetes not using insulin improve blood sugar control in a randomized trial, adding new fuel to the industry’s push to bring CGMs into broader primary care use.
ResMed has closed its $340 million acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes the sleep tech giant beyond its core sleep apnea and respiratory care businesses.
Treeline Biosciences, an under-the-radar cancer company that has raised more than $1 billion since its 2021 founding, is looking to step into the spotlight of the public market. Treeline has announced plans to merge with omics outfit Standard BioTools and secure a listing on the Nasdaq.